FRZB
Basic information
Region (hg38): 2:182833275-182866637
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FRZB gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 21 | 24 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 5 | 3 |
Variants in FRZB
This is a list of pathogenic ClinVar variants found in the FRZB region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-182834857-G-C | FRZB-related disorder • Osteoarthritis susceptibility 1 | Benign; risk factor (Dec 03, 2019) | ||
2-182834916-C-T | not specified | Uncertain significance (Nov 24, 2024) | ||
2-182834921-A-G | Benign (Jul 01, 2024) | |||
2-182834946-C-T | not specified | Uncertain significance (Oct 09, 2024) | ||
2-182834955-A-G | Benign/Likely benign (Aug 01, 2023) | |||
2-182837942-G-T | Likely benign (Jul 20, 2018) | |||
2-182837962-C-T | not specified | Uncertain significance (May 24, 2024) | ||
2-182837994-C-G | not specified | Uncertain significance (Jan 10, 2023) | ||
2-182838415-C-T | not specified | Uncertain significance (Jun 11, 2021) | ||
2-182838416-G-A | not specified | Uncertain significance (Feb 01, 2023) | ||
2-182838419-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
2-182838453-A-G | FRZB-related disorder | Likely benign (May 23, 2019) | ||
2-182838454-T-C | not specified | Uncertain significance (Apr 23, 2024) | ||
2-182838491-T-C | not specified | Uncertain significance (Feb 10, 2023) | ||
2-182838499-T-C | not specified | Uncertain significance (May 04, 2023) | ||
2-182838519-G-T | not specified | Uncertain significance (Apr 07, 2023) | ||
2-182838545-C-T | not specified | Uncertain significance (Dec 04, 2024) | ||
2-182838584-T-C | not specified | Uncertain significance (Nov 20, 2024) | ||
2-182838593-C-T | not specified | Uncertain significance (Nov 07, 2024) | ||
2-182838608-G-A | FRZB-related disorder • Osteoarthritis susceptibility 1 | Benign; risk factor (Jun 08, 2024) | ||
2-182838613-A-G | not specified | Uncertain significance (Aug 04, 2023) | ||
2-182842492-T-C | not specified | Uncertain significance (Oct 17, 2024) | ||
2-182842506-C-A | not specified | Uncertain significance (Sep 20, 2023) | ||
2-182842514-T-C | not specified | Uncertain significance (Jun 05, 2023) | ||
2-182866090-T-C | not specified | Uncertain significance (Nov 07, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FRZB | protein_coding | protein_coding | ENST00000295113 | 6 | 33889 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00108 | 0.956 | 125711 | 0 | 37 | 125748 | 0.000147 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.949 | 156 | 193 | 0.808 | 0.0000106 | 2111 |
Missense in Polyphen | 63 | 80.232 | 0.78522 | 905 | ||
Synonymous | -0.462 | 77 | 72.0 | 1.07 | 0.00000376 | 640 |
Loss of Function | 1.79 | 7 | 14.3 | 0.490 | 6.70e-7 | 164 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000363 | 0.000362 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000214 | 0.000211 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000981 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Soluble frizzled-related proteins (sFRPS) function as modulators of Wnt signaling through direct interaction with Wnts. They have a role in regulating cell growth and differentiation in specific cell types. SFRP3/FRZB appears to be involved in limb skeletogenesis. Antagonist of Wnt8 signaling. Regulates chondrocyte maturation and long bone development.;
- Disease
- DISEASE: Osteoarthritis 1 (OS1) [MIM:165720]: A degenerative disease of the joints characterized by degradation of the hyaline articular cartilage and remodeling of the subchondral bone with sclerosis. Clinical symptoms include pain and joint stiffness often leading to significant disability and joint replacement. {ECO:0000269|PubMed:15210948}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
- Pathway
- WNT-Core;Adipogenesis;Hepatitis C and Hepatocellular Carcinoma;Endochondral Ossification;Wnt Canonical;Wnt Mammals
(Consensus)
Recessive Scores
- pRec
- 0.224
Intolerance Scores
- loftool
- 0.795
- rvis_EVS
- 0.44
- rvis_percentile_EVS
- 77.8
Haploinsufficiency Scores
- pHI
- 0.247
- hipred
- Y
- hipred_score
- 0.605
- ghis
- 0.455
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.876
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Frzb
- Phenotype
- normal phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- frzb
- Affected structure
- palate
- Phenotype tag
- abnormal
- Phenotype quality
- decreased length
Gene ontology
- Biological process
- skeletal system development;negative regulation of cell population proliferation;negative regulation of cell development;neural crest cell differentiation;negative regulation of Wnt signaling pathway;negative regulation of cell growth;non-canonical Wnt signaling pathway;positive regulation of apoptotic process;positive regulation of fat cell differentiation;convergent extension involved in organogenesis;canonical Wnt signaling pathway;negative regulation of cartilage development;somite development;negative regulation of hepatocyte differentiation;negative regulation of canonical Wnt signaling pathway;cochlea morphogenesis
- Cellular component
- extracellular space;cytoplasm;membrane
- Molecular function
- Wnt-protein binding